Latin America Mice Model Market (2025-2030)
The Latin America Mice Model Market was valued at $35.6 Million in 2025 and projected to reach to $47.9 Million by 2030, representing a compound annual growth rate of 6.1%. Latin America's mice model market is experiencing steady growth driven by expanding pharmaceutical development activities and increased investment in biomedical research infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Latin America Mice Model Market Trends and Insights
- Latin America's mice model market is driven by increasing investment in biomedical research, expanding pharmaceutical development activities, and growing adoption of preclinical testing standards across the region.
- Latin America continues to strengthen its position as a hub for contract research organizations and academic institutions that rely on mice models for drug discovery and disease research. In 2025, Latin America's mice model market reflects rising demand from both public and private research sectors seeking cost-effective alternatives to other model organisms.
- By 2030, Latin America is expected to see accelerated growth fueled by regulatory harmonization with international standards, increased government funding for life sciences, and partnerships between regional institutions and global pharmaceutical companies.
- Latin America's market expansion is supported by improved breeding facilities, enhanced quality control measures, and greater awareness of the ethical and scientific advantages of standardized mice models in preclinical research..
Key Market Statistics
- CAGR (2025-2030) 6.1% CAGR
- Market Size, 2025 ~USD 35.6 Million
- Forecast, 2030 ~USD 47.9 Million
- Geography Latin America
Latin America Mice Model Market Overview
Market Valuation & Growth :
Latin America's mice model market is valued at $35.6 million in 2025 and is projected to reach $47.9 million by 2030, with a CAGR of 6.1%, outpacing several developed regions.
Brazil's Market Leadership :
Brazil dominates the Latin American mice model market with $16.96 million in market size, representing the largest biomedical research hub in the region with expanding pharmaceutical development infrastructure.
Rising Biomedical Investment :
Increasing government and private sector investment in biomedical research across Latin America is driving demand for preclinical testing models and standardized research protocols.
Regulatory Standardization :
Growing adoption of international preclinical testing standards and regulatory compliance requirements are accelerating the adoption of mice models in pharmaceutical development across the region.
Latin America Mice Model Market Dynamics
- The region is witnessing a shift toward standardized preclinical testing practices, with Brazil leading market expansion due to its robust research ecosystem and pharmaceutical manufacturing base.
- Government initiatives supporting life sciences research and growing collaboration with international pharmaceutical companies are expected to sustain market momentum through 2030.
- The market's 6.1% CAGR reflects emerging opportunities as Latin American institutions strengthen their research capabilities and regulatory frameworks align with global standards..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Latin America's mice model market is valued at $35.6 million in 2025 and will reach $47.9 million by 2030, growing at a 6.1% CAGR.
- Latin America is experiencing increased adoption of mice models driven by expanding pharmaceutical R&D and contract research organization activity.
- Latin America's market growth is supported by regulatory alignment with international standards and improved breeding infrastructure.
- Latin America's mice model market benefits from cost advantages and growing partnerships between regional and global research institutions.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area, End User |
Latin America Mice Model Market Report Segmentation
6 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
By End User
- Academic & Research Institutes
- Contract Research Organizations (Cros) & Contract Development And Manufacturing Organizations (Cdmos)
- Pharmaceutical & Biotechnology Companies
Target Audience
- Pharmaceutical Companies : Pharmaceutical manufacturers expanding preclinical research operations in Latin America need market data to optimize resource allocation, identify partnership opportunities, and navigate regional regulatory requirements.
- Contract Research Organizations (CROs) : CROs operating in Latin America require detailed market insights to assess demand for mice model services, benchmark pricing strategies, and identify growth opportunities in emerging markets.
- Research Institutions & Universities : Academic and research institutions in Latin America need market intelligence to secure funding, justify research investments, and align their capabilities with regional and global research trends.
- Biotech & Life Sciences Investors : Investors evaluating opportunities in Latin American biotech require comprehensive market data to assess market potential, competitive dynamics, and growth trajectories for informed investment decisions.
- Government & Regulatory Bodies : Latin American health authorities and government agencies need market insights to develop science policies, allocate research funding, and establish regulatory frameworks supporting biomedical innovation.
Key Companies in the Latin America Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Countries within Latin America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Brazil | USD 16.96 Million |
| Mexico | USD 6.85 Million |
| Rest Of Latin America | USD 24.1 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights into Latin America's mice model market with country-level breakdown including Brazil ($16.96M) and Mexico ($6.85M), enabling targeted market entry strategies.
- Growth Opportunity Assessment : Identify high-growth segments within Latin America's 6.1% CAGR market trajectory, with forecasts through 2030 to support long-term business planning and investment decisions.
- Competitive Landscape Analysis : Understand Latin America's unique market dynamics, regulatory environment, and pharmaceutical development trends to benchmark against global markets and identify competitive advantages.
- Investment & Expansion Planning : Access actionable intelligence on biomedical research investment patterns and preclinical testing adoption rates across Latin American countries to guide expansion strategies.
- Regulatory & Compliance Insights : Stay informed on evolving preclinical testing standards and regulatory requirements specific to Latin America, ensuring compliance and operational efficiency in the region.
Frequently asked questions
What is the current size of the mice model market in Latin America?
The Latin America mice model market is valued at $35.6 million in 2025.
What is the projected market size for mice models in Latin America by 2030?
Latin America's mice model market is projected to reach $47.9 million by 2030.
What is the growth rate of the mice model market in Latin America?
The Latin America mice model market is expected to grow at a compound annual growth rate of 6.1% from 2025 to 2030.
What factors are driving growth in Latin America's mice model market?
Latin America's market growth is driven by increased biomedical research investment, expanding pharmaceutical development, regulatory harmonization, improved breeding facilities, and growing partnerships with global research institutions.
Why are mice models important for research in Latin America?
Mice models are essential for preclinical drug testing, disease research, and biomedical studies in Latin America, offering cost-effective alternatives while meeting international ethical and scientific standards.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
- Rest Of Latin America Mice Model Market
- Ksa Mice Model Market
- Other GCC Countries Mice Model Market
- UAE Mice Model Market
- GCC Countries Mice Model Market
- Rest Of The Middle East Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report